JP2017080507A5 - - Google Patents

Download PDF

Info

Publication number
JP2017080507A5
JP2017080507A5 JP2017003854A JP2017003854A JP2017080507A5 JP 2017080507 A5 JP2017080507 A5 JP 2017080507A5 JP 2017003854 A JP2017003854 A JP 2017003854A JP 2017003854 A JP2017003854 A JP 2017003854A JP 2017080507 A5 JP2017080507 A5 JP 2017080507A5
Authority
JP
Japan
Prior art keywords
pharmaceutical preparation
cells
administered
suspension
amount
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017003854A
Other languages
English (en)
Japanese (ja)
Other versions
JP6382360B2 (ja
JP2017080507A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2017080507A publication Critical patent/JP2017080507A/ja
Publication of JP2017080507A5 publication Critical patent/JP2017080507A5/ja
Application granted granted Critical
Publication of JP6382360B2 publication Critical patent/JP6382360B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2017003854A 2004-03-22 2017-01-13 間葉幹細胞及びその使用法 Expired - Lifetime JP6382360B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US55511804P 2004-03-22 2004-03-22
US60/555,118 2004-03-22

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2012058539A Division JP6114500B2 (ja) 2004-03-22 2012-03-15 間葉幹細胞及びその使用法

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2017155229A Division JP6757300B2 (ja) 2004-03-22 2017-08-10 間葉幹細胞及びその使用法

Publications (3)

Publication Number Publication Date
JP2017080507A JP2017080507A (ja) 2017-05-18
JP2017080507A5 true JP2017080507A5 (enExample) 2017-08-31
JP6382360B2 JP6382360B2 (ja) 2018-08-29

Family

ID=46060822

Family Applications (8)

Application Number Title Priority Date Filing Date
JP2012058539A Expired - Lifetime JP6114500B2 (ja) 2004-03-22 2012-03-15 間葉幹細胞及びその使用法
JP2014241859A Expired - Lifetime JP5997237B2 (ja) 2004-03-22 2014-11-28 間葉幹細胞及びその使用法
JP2017003854A Expired - Lifetime JP6382360B2 (ja) 2004-03-22 2017-01-13 間葉幹細胞及びその使用法
JP2017155229A Expired - Lifetime JP6757300B2 (ja) 2004-03-22 2017-08-10 間葉幹細胞及びその使用法
JP2018190636A Expired - Lifetime JP6757383B2 (ja) 2004-03-22 2018-10-09 間葉幹細胞及びその使用法
JP2020047240A Expired - Lifetime JP7033159B2 (ja) 2004-03-22 2020-03-18 間葉幹細胞及びその使用法
JP2021140167A Expired - Lifetime JP7546239B2 (ja) 2004-03-22 2021-08-30 間葉幹細胞及びその使用法
JP2023023996A Pending JP2023065486A (ja) 2004-03-22 2023-02-20 間葉幹細胞及びその使用法

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2012058539A Expired - Lifetime JP6114500B2 (ja) 2004-03-22 2012-03-15 間葉幹細胞及びその使用法
JP2014241859A Expired - Lifetime JP5997237B2 (ja) 2004-03-22 2014-11-28 間葉幹細胞及びその使用法

Family Applications After (5)

Application Number Title Priority Date Filing Date
JP2017155229A Expired - Lifetime JP6757300B2 (ja) 2004-03-22 2017-08-10 間葉幹細胞及びその使用法
JP2018190636A Expired - Lifetime JP6757383B2 (ja) 2004-03-22 2018-10-09 間葉幹細胞及びその使用法
JP2020047240A Expired - Lifetime JP7033159B2 (ja) 2004-03-22 2020-03-18 間葉幹細胞及びその使用法
JP2021140167A Expired - Lifetime JP7546239B2 (ja) 2004-03-22 2021-08-30 間葉幹細胞及びその使用法
JP2023023996A Pending JP2023065486A (ja) 2004-03-22 2023-02-20 間葉幹細胞及びその使用法

Country Status (5)

Country Link
JP (8) JP6114500B2 (enExample)
AT (1) ATE556134T1 (enExample)
CA (3) CA2934682C (enExample)
ES (7) ES2544689T3 (enExample)
TR (1) TR201901268T4 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005093044A1 (en) * 2004-03-22 2005-10-06 Osiris Therapeutics, Inc. Mesenchymal stem cells and uses therefor
ES2544689T3 (es) * 2004-03-22 2015-09-02 Mesoblast International Sàrl Células madre mesenquimales y usos de las mismas
WO2014098960A2 (en) * 2012-05-16 2014-06-26 The Johns Hopkins University Stem cells as an individualized maternal therapy for prevention of prematurity
JP2016210730A (ja) * 2015-05-08 2016-12-15 上田　実 医薬組成物及びその製造方法並びに医薬品
WO2018092769A1 (ja) 2016-11-15 2018-05-24 株式会社カネカ 胎児付属物に由来する間葉系幹細胞を含む細胞集団とその製造方法、及び医薬組成物
AU2018372631B2 (en) 2017-11-22 2025-06-05 Mesoblast International Sarl Cellular compositions and methods of treatment I
JP7454379B2 (ja) 2017-12-28 2024-03-22 株式会社カネカ 接着性幹細胞を含む細胞集団とその製造方法、及び医薬組成物
JP7530893B2 (ja) 2019-06-14 2024-08-08 株式会社カネカ 間葉系細胞を含む細胞集団、それを含む医薬組成物、及び、その製造方法
CA3148582A1 (en) * 2019-08-15 2021-02-18 Nextcell Pharma Ab Allogeneic composition for treatment of cns disorders
CN113813288B (zh) * 2021-08-11 2024-02-13 谢岩 间充质干细胞及包含其的组合物用于制备治疗烧伤难愈创面的药物的用途

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0651641B2 (ja) * 1983-08-29 1994-07-06 株式会社ミドリ十字 ガンマ・インターフェロン組成物
WO1987005518A1 (en) * 1986-03-17 1987-09-24 Schering Corporation Treatment of cancers with gamma interferon
JPH10501815A (ja) * 1994-06-07 1998-02-17 リージェンツ・オブ・ザ・ユニバーシティ・オブ・ミネソタ 抗原特異的ｔ細胞応答の阻害方法
AU2808397A (en) * 1996-04-26 1997-11-19 Case Western Reserve University Skin regeneration using mesenchymal stem cells
EP1066052B1 (en) * 1998-03-18 2006-02-01 Osiris Therapeutics, Inc. Mesenchymal stem cells for prevention and treatment of immune responses in transplantation
US6368636B1 (en) * 1998-03-18 2002-04-09 Osiris Therapeutics, Inc. Mesenchymal stem cells for prevention and treatment of immune responses in transplantation
US6797269B2 (en) * 1998-04-03 2004-09-28 Osiris Therapeutics, Inc. Mesenchymal stem cells as immunosuppressants
EP1252308A2 (en) * 2000-01-19 2002-10-30 Parkash S. Gill Pharmaceutical compositions and methods of treatment based on vegf antisense oligonucleotides
DE60143517D1 (de) * 2000-04-25 2011-01-05 Osiris Therapeutics Inc Wiederherstellung der gelenken mit mesenchymalen stammzellen
AU2003208888B2 (en) * 2002-02-01 2006-10-19 Merck Sharp & Dohme Llc Uses of mammalian cytokine; related reagents
JP3897343B2 (ja) * 2002-08-01 2007-03-22 株式会社林原生物化学研究所 免疫担当細胞においてインターフェロン−γの産生を誘導する蛋白質
US20040258670A1 (en) * 2002-12-05 2004-12-23 Case Western Reserve University Cell-based therapies for ischemia
WO2005093044A1 (en) * 2004-03-22 2005-10-06 Osiris Therapeutics, Inc. Mesenchymal stem cells and uses therefor
ES2544689T3 (es) * 2004-03-22 2015-09-02 Mesoblast International Sàrl Células madre mesenquimales y usos de las mismas

Similar Documents

Publication Publication Date Title
JP2017080507A5 (enExample)
JP2018009002A5 (enExample)
JP2014519911A5 (enExample)
JP2018109052A5 (enExample)
JP2017081972A5 (enExample)
JP2009543579A5 (enExample)
RU2014137321A (ru) ГИСТИДИЛ-тРНК-СИНТЕТАЗЫ ДЛЯ ЛЕЧЕНИЯ АУТОИММУННЫХ И ВОСПАЛИТЕЛЬНЫХ ЗАБОЛЕВАНИЙ
JP2018526447A5 (enExample)
JP2013544244A5 (enExample)
Reynolds et al. Improving cardiovascular outcomes in rheumatic diseases: therapeutic potential of circulating endothelial progenitor cells
JP2012506394A5 (enExample)
JP2013519363A5 (enExample)
JP2014513126A5 (enExample)
CN103284988A (zh) 炔丙基半胱氨酸及其类似物在制备治疗免疫相关炎症疾病药物中的用途
RU2012101995A (ru) Фармацевтический агент
JP2013510905A5 (enExample)
Thipphawong Inhaled cytokines and cytokine antagonists
CN106619619A (zh) 化合物hubin‑1在制备肝脏炎症性疾病预防和/或治疗药物中的用途
CN115038445A (zh) 用于治疗炎性疾病的新型药物
Hawthorne et al. 1.12 MIF Enhances Human Mesenchymal Stromal Cell Longevity In Vivo In Allergic Airway Inflammation
Li et al. The pivotal role of cytokines in liver disease pathogenesis and therapeutic potential
CN106421796B (zh) 索拉菲尼联合ccr4拮抗剂在抑制癌生长及转移中的应用
Zhang et al. Effects of spheroid culture in a rotating bioreactor on secretion of inflammatory factors by human placenta-derived mesenchymal stem cells
Feng et al. Interfacial-engineered living drugs with “ON/OFF” switching for oral delivery
Dai Xiao-sen et al. Effects of stromal cell-derived factor-1 and its receptor CXCR4 on the migration of endogenous neural stem cells